The tools being offered to your practice for free may carry a price that nobody has told you about.
ModuleMD Editorial
Trusted insights for independent practice
Let's start with something we all know to be true: the administrative burden on physicians has become genuinely unsustainable. Prior authorizations, prescription routing, insurance appeals — these processes consume hours that should belong to patients. So when a technology platform arrives promising to handle all of it, automatically, and for free, the relief is understandable. Of course you'd consider it.
But it's worth pausing to ask a question that doesn't get asked often enough in healthcare: when a sophisticated, venture-backed technology company offers a complex service at no charge, who is actually paying for it — and what are they getting in return?
The "Free Tool" Business Model
Across the technology industry, the pattern is well established. A platform is offered at no cost to build rapid adoption. The real product being sold is not the tool itself — it's the data generated by the people using it, and the network access that scale provides. In consumer technology this gave us search engines and social media. In healthcare, the stakes are considerably higher.
When prescription workflows, patient medication histories, prior authorization outcomes, and clinical decision patterns flow through a centralized platform, that data has enormous commercial value — particularly to pharmaceutical and life sciences companies trying to understand prescribing behavior, patient populations, and how their drugs perform in the real world.
The people generating the most valuable data in this equation — physicians and their patients — are typically the last to see any of the financial benefit.
This isn't hypothetical. It's a well-worn model in health data. The important question for physicians is not whether this happens, but whether they and their patients have meaningfully consented to it — and whether the exchange is fair.
What It Means for Your Practice Long Term
Beyond data, there's a structural question worth considering. When clinical workflow and prescription intelligence become deeply embedded in a third-party platform, a gradual shift begins. The knowledge of what works for which patient — knowledge that physicians have built through years of training and clinical experience — gets encoded into a system owned by someone else. Over time, the platform becomes indispensable. Switching costs grow. And the entity with leverage in the relationship is no longer the physician.
History offers instructive parallels. Physicians who watched the adoption of electronic health record systems in the early 2000s with optimism will remember how the promise of efficiency gave way to documentation burdens, interoperability failures, and contracts that made changing systems nearly impossible. The pattern of technology entering healthcare with a helpful face and embedding itself as a toll-collecting layer is not new.
Practical Checklist
Questions Worth Asking Before You Adopt Any Platform
- → Who has access to the patient and prescribing data generated through this tool, and for what purposes?
- → Is patient data de-identified before being shared, and by whose definition of de-identification?
- → What does your state's patient privacy notice actually disclose about downstream data use?
- → Who are the investors behind this company, and what return do they need to achieve — and by when?
- → What happens to your workflow and patient data if this company is acquired, changes its terms, or shuts down?
- → Does your patient population include vulnerable groups for whom data exposure carries additional risk?
A Different Way to Think About It
None of this means that technology cannot genuinely serve physicians and patients well. It can, and it should. Administrative friction in prescription management is a real problem that causes real harm — patients who never fill their prescriptions, treatments delayed by paperwork, physicians spending evenings on hold with insurance companies. These are worth solving.
The question is whether the solution should be structured so that the primary beneficiary is a private investor looking for a large exit, or the physicians and patients the tool claims to serve. Those are not the same thing, and the structure of a business tends to determine its priorities over time — especially when outside capital demands a return.
Mature, well-governed tools built on transparent business models — where physicians understand exactly what they're adopting and why it's sustainable — are worth seeking out, even if they require a more careful evaluation upfront. Your practice, your patients, and your professional autonomy are worth that diligence.
As AI continues to reshape healthcare administration, the physicians who ask these questions now will be far better positioned than those who don't.
